LI-RADS v2018 category and imaging features: inter-modality agreement between contrast-enhanced CT, gadoxetate disodium-enhanced MRI, and extracellular contrast-enhanced MRI

被引:0
作者
Agnello, Francesco [1 ]
Cannella, Roberto [1 ]
Brancatelli, Giuseppe [1 ]
Galia, Massimo [1 ]
机构
[1] Univ Palermo, Dept Radiol, Policlin Paolo Giaccone, Via Vespro 127, I-90127 Palermo, Italy
来源
RADIOLOGIA MEDICA | 2024年 / 129卷 / 11期
关键词
LI-RADS; CT; MRI; Liver; Contrast media; GD-EOB-DTPA; FOCAL LIVER-LESIONS; SMALL HEPATOCELLULAR-CARCINOMA; COMPUTED-TOMOGRAPHY; DELAYED PHASE; DIAGNOSTIC PERFORMANCE; SIGNAL-INTENSITY; HEPATIC NODULES; CIRRHOTIC LIVER; ACID;
D O I
10.1007/s11547-024-01879-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PurposeTo perform an intra-individual comparison of LI-RADS category and imaging features in patients at high risk of hepatocellular carcinoma (HCC) on contrast-enhanced CT, gadoxetate disodium-enhanced MRI (EOB-MRI), and extracellular agent-enhanced MRI (ECA-MRI) and to analyze the diagnostic performance of each imaging modality.MethodThis retrospective study included cirrhotic patients with at least one LR-3, LR-4, LR-5, LR-M or LR-TIV observation imaged with at least two imaging modalities among CT, EOB-MRI, or ECA-MRI. Two radiologists evaluated the observations using the LI-RADS v2018 diagnostic algorithm. Reference standard included pathologic confirmation and imaging criteria according to LI-RADS v2018. Imaging features were compared between different exams using the McNemar test. Inter-modality agreement was calculated by using the weighted Cohen's kappa (k) test.ResultsA total of 144 observations (mean size 34.0 +/- 32.4 mm) in 96 patients were included. There were no significant differences in the detection of major and ancillary imaging features between the three imaging modalities. When considering all the observations, inter-modality agreement for category assignment was substantial between CT and EOB-MRI (k 0.60; 95%CI 0.44, 0.75), moderate between CT and ECA-MRI (k 0.46; 95%CI 0.22, 0.69) and substantial between EOB-MRI and ECA-MRI (k 0.72; 95%CI 0.59, 0.85). In observations smaller than 20 mm, inter-modality agreement was fair between CT and EOB-MRI (k 0.26; 95%CI 0.05, 0.47), moderate between CT and ECA-MRI (k 0.42; 95%CI -0.02, 0.88), and substantial between EOB-MRI and ECA-MRI (k 0.65; 95%CI 0.47, 0.82). ECA-MRI demonstrated the highest sensitivity (70%) and specificity (100%) when considering LR-5 as predictor of HCC.ConclusionsInter-modality agreement between CT, ECA-MRI, and EOB-MRI decreases in observations smaller than 20 mm. ECA-MRI has the provided higher sensitivity for the diagnosis of HCC.
引用
收藏
页码:1575 / 1586
页数:12
相关论文
共 50 条
  • [21] Severe acute pancreatitis: contrast-enhanced CT and MRI features
    Piironen, A
    ABDOMINAL IMAGING, 2001, 26 (03): : 225 - 233
  • [22] Severe acute pancreatitis: Contrast-enhanced CT and MRI features
    Piironen A.
    Abdominal Imaging, 2001, 26 (3): : 225 - 233
  • [23] LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium enhanced MRI
    Lee, Sang Min
    Lee, Jeong Min
    Ahn, Su Joa
    Kang, Hyo-Jin
    Yang, Hyun Kyung
    Yoon, Jeong Hee
    RADIOLOGY, 2019, 292 (03) : 655 - 663
  • [24] Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS
    Dong Ik Cha
    Gyu Seong Choi
    Young Kon Kim
    Jong Man Kim
    Tae Wook Kang
    Kyoung Doo Song
    Soo Hyun Ahn
    European Radiology, 2020, 30 : 3723 - 3734
  • [25] Fat Containing HCC: Findings on CT and MRI Including Serial Contrast-Enhanced Imaging
    Balci, N. Cem
    Befeler, Alex S.
    Bieneman, B. Kirke
    Fattahi, Rana
    Saglam, Sezer
    Havlioglu, Necat
    ACADEMIC RADIOLOGY, 2009, 16 (08) : 963 - 968
  • [26] Hepatic schwannoma: Imaging findings on CT, MRI and contrast-enhanced ultrasonography
    Ota, Yu
    Aso, Kazunobu
    Watanabe, Kenji
    Einama, Takahiro
    Imai, Koji
    Karasaki, Hidenori
    Sudo, Ryuji
    Tamaki, Yosui
    Okada, Mituyoshi
    Tokusashi, Yosihiko
    Kono, Toru
    Miyokawa, Naoyuki
    Haneda, Masakazu
    Taniguchi, Masahiko
    Furukawa, Hiroyuki
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (35) : 4967 - 4972
  • [27] Inter-rater agreement in the characterization of cystic renal lesions on contrast-enhanced MRI
    Seppala, Nicholas
    Kielar, Ania
    Dabreo, Dominique
    Duigenan, Shauna
    ABDOMINAL IMAGING, 2014, 39 (06): : 1267 - 1273
  • [28] LI-RADS version 2018 for hepatocellular carcinoma < 1.0 cm on gadoxetate disodium-enhanced magnetic resonance imaging
    Jang, Hyeon Ji
    Choi, Sang Hyun
    Choi, Se Jin
    Choi, Won-Mook
    Byun, Jae Ho
    Won, Hyung Jin
    Shin, Yong Moon
    EUROPEAN RADIOLOGY, 2023, 33 (08) : 5792 - 5800
  • [29] Combined Hepatocellular and Cholangiocarcinoma (Biphenotypic) Tumors: Imaging Features and Diagnostic Accuracy of Contrast-Enhanced CT and MRI
    Fowler, Kathryn J.
    Sheybani, Arman
    Parker, Rex A., III
    Doherty, Sean
    Brunt, Elizabeth M.
    Chapman, William C.
    Menias, Christine O.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2013, 201 (02) : 332 - 339
  • [30] Additional value of 10-min far-delayed phase in extracellular contrast agent-enhanced MRI for diagnostic performance of hepatocellular carcinoma based on LI-RADS v2018
    Wang, Jiahui
    Sun, Wei
    Qiu, Qiansai
    Dong, Sanyuan
    Chen, Xiaoshan
    Wang, Wentao
    Yang, Yutao
    Rao, Shengxiang
    CHINESE JOURNAL OF ACADEMIC RADIOLOGY, 2025, 8 (01) : 24 - 34